In 1992 and 1993, we published two papers that described the structure of the Src homology 2 (SH2) domain of the v-Src tyrosine kinase complexed to nonspecific phosphotyrosyl peptides (Waksman et al., 1992) and to a phosphopeptide that has specificity for the Src SH2 domain (Waksman et al., 1993) . These papers mark the beginnings of a research effort on the Src kinases that has resulted ten years later in the structure of the autoinhibited form of the Src relative c-Abl, providing an explanation for how the different utilization of the SH2 domain in c-Abl and c-Src underlies the ability of the cancer drug Gleevec to inhibit Abl but not Src (Nagar et al., 2003) . In this commentary, we discuss how our initial experiments on Src began and describe some of the factors that led to the rapid determination of the SH2 structure.
The SH2 (Src homology 2) domain was discovered by Tony Pawson in 1986, who identified it as a block of sequence spanning approximately 100 residues that is conserved amongst v-Src and other nonreceptor tyrosine kinases (Sadowski et al., 1986 ). Pawson's early studies indicated that the SH2 domain, located upstream of the catalytic domain in Src and related tyrosine kinases, is not essential for catalytic activity but appeared instead to play a role in the regulation of the signaling properties of these proteins. Work in the Hanafusa laboratory on the newly discovered v-crk oncogene led to the identification of a second modular domain, named SH3, that often works in concert with SH2 domains (Mayer et al., 1988) . We were particularly excited by the discovery of v-Crk, since this protein contains only SH2 and SH3 domains, and yet was capable of binding to tyrosine phosphorylated proteins and stimulating tyrosine kinase activity in cells (Matsuda et al., 1990; Mayer and Hanafusa, 1990) . Studies on v-Crk and also on the epidermal growth factor (EGF) receptor and the platelet-derived growth factor (PDGF) receptors established that SH2 domains bind to phosphorylated tyrosine residues, making the SH2 domain the first of the modular targeting devices to be discovered and characterized (Anderson et al., 1990; Kazlauskas et al., 1990; Matsuda et al., 1990; Moran et al., 1990 ). This marked a profound shift in how we think about intracellular signaling, since receptor-mediated protein clustering is a *Correspondence: kuriyan@uclink.berkeley.edu mechanism that contrasts markedly with signal propagation mechanisms that rely on the diffusion of small molecule second messengers.
The late 1980s also saw major advances in our understanding of how the tyrosine kinases of the Src family are regulated. An intramolecular interaction between a phosphotyrosine residue in the C-terminal tail of the Src protein was shown to inactivate the tyrosine kinase domain (see Roussel et al., 1991 and references therein; reviewed in Thomas and Brugge, 1997) . Thus, a dual role for the Src SH2 domain in "turning inwards" and regulating the kinase activity of Src and "turning outwards" and directing the appropriate localization of Src kinases emerged from these studies. The race was on to determine the three-dimensional structure of the SH2 domain and to more clearly map out its function.
In the late 1980s and early 1990s, when these hypotheses regarding Src kinase regulation were being validated, our concept of the modular "mix and match" architecture of complex proteins was still relatively unformed. Studies in transcription had prepared us for the idea that complex proteins are constructed from relatively independent domains with distinct functions, as witnessed by the separability of the DNA binding and other functional domains of many transcription factors (an early demonstration of this principle is given by Pabo et al., 1979) . Nevertheless, our view of protein structure in the 1980s remained focused on the tightly integrated architecture of autonomous functional units, whether complex or simple. In this regard, we did not know quite what to make of the SH2 domain: was it reasonable to think of it as a separable functional module, as the biological experiments were beginning to suggest? Or would the very act of pulling the domain out of its proper context scramble its proper function?
Prior to the early 1990s attempts to determine the structures of large and complex proteins often met with failure. One central problem that was not always recognized at that time is that flexible segments or linkages can be a severe impediment to crystallization. Flexible linkages in proteins can be mapped using limited protease digestion, a classical method that is still an important component of the biochemist's tool kit. Despite the ease with which this method can be applied, it is difficult to obtain precise molecular boundaries without highresolution mass spectrometric analysis of the resulting fragments. The application of mass spectrometry to protein analysis was gaining momentum in the late 1980s, but when we began our studies on the SH2 domain mass spectrometry was not quite ready for mapping domain boundaries in a routine manner.
What really got the structural analysis of the Src SH2 domain off to a flying start despite these various sources of confusion was the fact that so many proteins that are functionally unrelated to tyrosine kinases were found to contain SH2 domains (Koch et al., 1991) . These included phosphatidyl inositol 3-OH kinase, phospholipase C~/1, ras GTPase-activating protein (Ras-GAP), and certain protein tyrosine phosphatases. The presence of clearly recognizable SH2 domains in such diverse backgrounds suggested strongly that the domain is indeed an independently folding unit, with boundaries that are readily defined. We now know that many SH2 domains are quite divergent in sequence from the canonical ones and had these been included the definition of the domain boundaries would not have been so easy. Indeed, some SH2 domains, such as those in the STAT proteins, cannot be separated from their parent proteins without structural disruption.
Our good fortune in being able to pick the correct boundaries of the SH2 domain was followed by a bonanza in protein expression. Using a standard bacterial expression system with no affinity tags, we were able to routinely purify tens of milligrams of soluble SH2 domain from one liter of bacterial culture. This breakthrough occurred at a time when structural biology groups, such as ours, were making important strategic changes in how we approached the expression and pudfication of target proteins. In the past, purified protein would be delivered to us by our collaborators or, in some cases, we would purify proteins ourselves, but use expression constructs that had been developed by our collaborators. Relatively little thought was given to the definition of the protein construct used and hardly any to what comparative sequence analysis might teach us about how best to tackle the protein. As we developed plans to work on the Src kinases it became clear that a successful approach would have to marry molecular biology to protein expression and purification right from the start. One of us (G.W.) had been trained as a molecular biologist and came to the Rockefeller University to apply molecular biology to a structural attack on the Src problem in the nascent research group of the other (J.K.). The Rockefeller University was a particularly stimulating environment for thinking about how best to solve the Src structure. In addition to Hidesaburo Hanafusa, who was our main source for guidance and insight, we engaged in many discussions with David Cowbum, who began an analysis of the Abl SH2 domain by NMR in collaboration with David Baltimore (then at the Rockefeller University) and his postdoctoral fellow Bruce Mayer (formerly a student of Hanafusa's) and Marilyn Resh (at Memorial Sloan-Kettering Cancer Center, across the street from us).
We began by trying to crystallize the Src SH2 domain by itself, and relatively quickly obtained large crystals that diffracted X-rays to high resolution (better than 1.5 A). Our initial excitement at seeing the spectacular extent of the first diffraction patterns quickly changed to chagrin when we realized that the diffraction patterns indicated a critical flaw in the crystals: along certain directions the diffraction pattern consisted of rows of sharp spots (a characteristic feature of X-ray diffraction from nicely ordered crystals) alternating with rows of diffraction lines that were not clearly resolved into individual spots. No matter what we tried we could not resolve individual spots within these alternating rows of streaky diffraction, and we had to conclude reluctantly that our crystals were intrinsically disordered in some way. An intensive hunt for an alternate crystal form led to the discovery that the addition of phosphate ions led to crystals that diffracted X-rays to not as high a resolution (2.5 A), but without any evidence for the streaky diffraction that had plagued our analysis of the earlier crystals. Unfortunately, these crystals were so sensitive to handling that we could not proceed with structure determination at that time, although we did eventually return to these crystals to obtain the structure of the uncomplexed SH2 domain, described in our 1993 Cell paper.
These problems with the Src SH2 crystals suggested that we needed to stabilize the protein molecule in some way, and the obvious route to this would be to add a peptide ligand. High-affinity ligands for the Src SH2 domain were not known at that time (the tail of c-Src relies on local concentration to achieve its effects, and is not by itself a high affinity ligand for the SH2 domain). Fortunately for us, David Cowburn and his postdoctoral fellow Nalin Pant were synthesizing phosphotyrosyl peptides corresponding to the SH2 binding sites on the PDGF and EGF receptors (Kashishian et al., 1992; Margolis et al., 1989) . Cowbum suggested to us that we ignore the fact that these peptides were probably not the biologically relevant targets for the Src SH2 domain, and add them to our crystallization mixtures. We did so, with some misgivings, but the results were remarkable: within hours of the addition of these peptides to the crystallization set-ups large single crystals of SH2-peptide complexes were visible. These crystals were ve~ stable, and diffracted X-rays to high resolution (1.5 A on a laboratory X-ray source), enabling structure determination to proceed. We now know that the phosphotyrosine residue contributes the bulk of the binding energy in most SH2 interactions (Bradshaw and Waksman, 2002) , but at that time we thought that a small miracle had occurred.
David Cowburn and his colleagues provided one more critical boost to the Src project, without which the Src SH2 structure would never have been completed as rapidly as it was. In order to solve the crystal structure, we needed phases for the X-ray amplitudes. Today, for bacterially expressed protein, all the phases required to obtain a high quality electron density map might be obtained in a couple of hours at a synchrotron source using multi-wavelength anomalous diffraction (MAD) measurements from selenium-labeled protein crystals (Hendrickson, 2000) . At that time, however, the MAD method had not come into general use, and neither had the techniques for minimizing radiation damage by collecting data at cryogenic temperatures. We attempted to solve the SH2 structure by forming heavy atom derivatives and using the method of multiple isomorphous replacements (MIR), pioneered by Max Perutz. Due to the inherent difficulties of this method our initial electron density maps were noisy and difficult to interpret. We could see the presence of two (x helices and a 13 sheet in the map, but the connectivity and direction of the secondary structural elements was not entirely clear. David Cowburn provided us with a detailed diagram, based on NMR (Overduin et al., 1992a) , showing the hydrogen bonding pattern that characterizes the secondary structure of the Abl SH2 domain, the NMR structural analysis of which was nearing completion at that time in his laboratory. Cowburn's diagram of the SH2 secondary structure was the key that allowed us to very rapidly complete a high resolution structure of the Src SH2 domain peptide complex without necessitating any further data collection. 1992 saw the simulta- neous publication of our paper on the Src SH2 domain phosphopeptide complex (Waksman et al., 1992) , as well as two NMR structures of uncomplexed SH2 domains, that of Abl from the Cowburn lab (Overduin et al., 1992b) and that of PI 3-OH kinase from Campbell and coworkers (Booker et al., 1992) .
While our first structures of the Src SH2 domain explained how these modules recognize phosphotyrosine, they provided no ready explanation for how particular SH2 domains recognize specific sequence contexts. Shortly after our first SH2 paper appeared, Lew Cantley told us that he and Songyang Zhou had mapped the sequence specificities of several SH2 domains using a peptide library approach. Given how the peptides bind in the Src SH2 structures we could generate models that explained the importance of residues located downstream of the phosphotyrosine residue, and the hydrophobicity and polarity of residues on the surface of the SH2 domain seemed to correlate with the observed patterns of specificities, such as that of the Src SH2 domain for peptides with the sequence Y'EEl, where Y* is phosphotyrosine. We wrote a short note on the results of our computer modeling and submitted it as a letter to the editor of Cell, hoping to have it published alongside the paper from Cantley and colleagues on SH2 specificity that had also been submitted to Cell. Benjamin Lewin, the founding editor of Cell, took a very long time to make up his mind about these papers, which perhaps reflects the fact that the importance of modular targeting units in eukaryotic signaling had barely begun to be recognized in the early 1990s.
While these papers were incubating in the offices of Cell, Steve Shoelson at Harvard synthesized phosphopeptides corresponding to the optimal Src SH2 target identified by Cantley (containing the Y'EEl motif). Shoelson provided these peptides to us and to Steve Harrison and Michael Eck at Harvard, who had been working independently on the SH2 domain of the Src kinase Lck. The synthesis of highly pure phosphotyrosyl peptides was an arcane art at that time, and Shoelson's peptides were crucial to the rapid and simultaneous determination, both at Rockefeller and at Harvard, of SH2 domains bound to specific peptides and for helping to resolve doubts in Lewin's mind about the importance of the results (Eck et al., 1993; Waksman et al., 1993) . These structures revealed the now canonical "two-pronged plug into two-holed socket" mode of peptide recognition by the Src and Lck SH2 domains (Figure 1) , and set the stage for the rigorous mapping of the thermodynamics of SH2 target selectivity (reviewed in Bradshaw and Waksman, 2002 When we were analyzing these first SH2 domains we found ourselves stretching for structural parallels to draw upon. Our initial comparison of the SH2 domain to proteases, immunoglobulins, or the MHC complex seems forced at best (Waksman et al., 1992) , because the transient and relatively loose interaction between the SH2 domain and its targets seems rather different from the tight and long-lived complexes seen in these other systems. Today, the SH2 domain is one amongst many well-characterized peptide recognition domains that function in signaling, such as the SH3, PDZ, WW, PTB, and FHA domains, and its properties seem unremarkable (Pawson and Nash, 2003). Looking back, we are grateful to have had the opportunity to work on the 
An Activity Phosphorylating Tyrosine in Polyoma T Antigen Immunoprecipitates
Walter Eckhart, Mary Anne Hutchinson and Tony Hunter Tumor Virology Laboratory The Salk Institute Post Office Box 85800 San Diego, California 92138 Summary Polyoma T antigen immunoprecipitates contain a protein kinase-iike activity which preferentially phosphorylates material of 50-60,000 daltons molecular weight. Phosphorylation is not diminished in extracts of polyoma tsA mutant-infected cells shifted to the nonpermissive temperature late in infection, conditions which inactivate the large T antigen. Phosphorylation is reduced or absent in cells infected with polyoma host range nontransforming (hr-t) mutants, which have defective small and medium T antigens. The major acceptor of phosphate is not the heavy chain of immunoglobulin, but appears to be the polyoma medium T antigen. The large T antigen is also phosphorylated, but usually to a lower specific activity. In terms of acid and alkali sensitivity and electrophoretic and chromatographic mobility in one and two dimensions, the phosphorylated residue behaves identically to phosphotyrosine and differently than phosphorylated serine, threonine, lysine and histidine.
Introduction
Cell transformation by polyoma virus involves at least two functions encoded in the early region of the viral genome (Eckhart, 1977; Fluck, Staneloni and Benjamin, 1977) . The proteins encoded in the early region are referred to as T antigens, and have been identified by immunoprecipitation of extracts of lytically infected or transformed cells (TQrler and Salomon, 1977; Ito, Spurr and Dulbecco, 1977b; Hutchinson, Hunter and Eckhart, 1978; Schaffhausen, Silver and Benjamin, 1978) or of the in vitro translation products of viral mRNA (Hunter, Hutchinson and Eckhart, 1978) , using serum from tumor-bearing animals. There are at least three T antigens encoded by polyoma (Ito, Brocklehurst and Dulbecco, 1977a; Smart and Ito, 1978; Hunter et al., 1978; Hutchinson et al., 1978; Schaffhausen et al., 1978) , referred to as large, medium and small, with molecular weights of approximately 90,000 (90K), 60,000 (60K) and 22,000 (22K) daltons, respectively. The three T antigens are encoded by overlapping nucleotide sequences in the viral DNA: the small t antigen between 74 and 85 map units on the circular physical map (Griffin, Fried and Cowie, 1974) of polyoma DNA; the medium T antigen between 74 and 85 and 86 and 99 map units; and the large T antigen between 74 and 79 and 86 and 24 map units (Smart and Ito, 1978; Hutchinson et al., 1978; G. Carmichael and T. Benjamin, unpublished results) . The medium and large T antigens are translated in different reading frames from the viral DNA between 86 and 99 map units (Hunter et al., 1979) .
Two classes of mutants in the early region affect cell transformation: the temperature-sensitive (tsA) mutants (Fried, 1965) and the host range nontransforming (hr-t) mutants (Benjamin, 1970) . The tsA mutants affect only the large T antigen (Ito et al., 1977b; Hutchinson et al., 1978) ; the hr-t mutants affect both the small and medium T antigens, but not the large T antigen (Schaffhausen et al., 1978) .
To understand the effects of the polyoma T antigens on cell growth regulation it will be necessary to identify their functions. The large T antigen is apparently responsible for the initiation of viral DNA replication (Francke and Eckhart, 1973) and affects the production of early mRNA (Cogen, 1978) . The small and/or medium T antigens are not required for lytic infection, except under certain conditions (Goldman and Benjamin, 1975) , but are required for abortive transformation after infection (Schlegel and Benjamin, 1978) .
The gene product of Rous sarcoma virus responsible for cell transformation (src) is associated with a protein kinase activity which phosphorylates the heavy chain of immunoglobulin in immunoprecipitates (Collett and Erikson, 1978; Levinson et al., 1978; RQbsamen, Friis and Bauer, 1979; Sefton, Hunter and Beemon, 1979) . The related product of the endogenous cellular sarc gene also appears to be associated with a protein kinase activity (Collett et al., 1979; Oppermann et al., 1979) . Immunoprecipitates of adenovirus T antigens contain a protein kinase activity (Lassam et al., 1979) . A protein consisting of most of the SV40 large T antigen fused to a portion of an unidentified adenovirus protein contains ATPase and protein kinase activity (Tjian and Robbins, 1979) , but the kinase activity separates from the bulk of the protein in highly purified preparations. We describe here a protein kinase-like activity present in immunoprecipitates of polyoma T antigens. The activity has the unusual specificity of phosphorylating tyrosine.
Results

Protein Kinase Activity in Immunoprecipitates
To test for protein kinase activity in immunoprecipitates containing polyoma T antigens we infected mouse 3T6 cells with wild-type polyoma, harvested the infected cultures during the late phase of lytic infection, precipitated infected cell extracts with rat anti-tumor serum and incubated the immunoprecipitates with ~J2P-ATP. We then analyzed the distribution of incorporated radioactivity by SDS-polyacryl-
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